Clinical Trial Update: CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients

View source ↗

Summary

A clinical trial evaluating circulating endothelial cells and endothelial progenitor cells to assess cardiovascular risk in renal transplant recipients has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: University of Florida | Conditions: Transplantation, Kidney, Cardiovascular Abnormalities | Status: TERMINATED